Trader consensus prices "No" at 79% implied probability for a CDC Level 4 "Avoid All Travel" health notice by December 31, 2026, reflecting the extreme rarity of such designations—none active currently or since the COVID-19 era—and stable epidemiological conditions without explosive outbreaks meeting the threshold of very high transmission risk or untreatable disease threats. Recent CDC updates, including a new Level 1 notice for ciguatera fish poisoning in Vanuatu on May 7 and a global dengue refresh on April 16, show no escalations from existing Level 2 alerts for clade II mpox in Ghana and Liberia or meningococcal disease in the Democratic Republic of the Congo. Ongoing surveillance of measles surges (Level 1 globally) and H5N1 avian influenza lacks evidence of sustained human-to-human spread warranting upgrade, though new WHO case reports or model projections could shift sentiment ahead of year-end resolution.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$71,394 Vol.
$71,394 Vol.
$71,394 Vol.
$71,394 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Market Opened: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader consensus prices "No" at 79% implied probability for a CDC Level 4 "Avoid All Travel" health notice by December 31, 2026, reflecting the extreme rarity of such designations—none active currently or since the COVID-19 era—and stable epidemiological conditions without explosive outbreaks meeting the threshold of very high transmission risk or untreatable disease threats. Recent CDC updates, including a new Level 1 notice for ciguatera fish poisoning in Vanuatu on May 7 and a global dengue refresh on April 16, show no escalations from existing Level 2 alerts for clade II mpox in Ghana and Liberia or meningococcal disease in the Democratic Republic of the Congo. Ongoing surveillance of measles surges (Level 1 globally) and H5N1 avian influenza lacks evidence of sustained human-to-human spread warranting upgrade, though new WHO case reports or model projections could shift sentiment ahead of year-end resolution.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions